Ticker
AGRX

Price
0.45
Stock movement down
-0.02 (-3.85%)
Company name
Agile Thrpe
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers-Specialty & Generic
Markedsverdi
14.18M
Ent verdi
36.99M
Pris/omsetning
2.47
Pris/bok
5.17
Utbytte avkastning
-
Utbytte vekst
-
Vekst år
-
FCF-utbetaling
-
Etterfølgende P/E
-
Fremtidig P/E
-
PEG
-
EPS-vekst
-
1 års avkastning
-98.95%
3 års avkastning
-78.16%
5 års avkastning
-67.92%
10 års avkastning
-
Sist oppdatert: 2022-08-25

UTBYTTE

AGRX betaler ikke utbytte

VERDSETTELSE

Verdsettelsesforhold

Loading...
Verdsettelsesforhold-data
Etterfølgende P/E-
Pris til OCF-
Pris til FCF-
Pris til EBITDA-
EV i forhold til EBITDA-

Verdsettelse (Salg/Bokført verdi)

Loading...
Verdsettelse (Salg/Bokført verdi) data
Pris til omsetning2.47
Pris til bok5.17
EV i forhold til salg6.44

ØKONOMI

Per aksje

Loading...
Per aksje-data
Gjeldende aksje antall31.51M
EPS (TTM)-0.74
FCF per aksje (TTM)-0.70

Resultatregnskap

Loading...
Resultatregnskap-data
Inntekter (TTM)5.75M
Bruttofortjeneste (TTM)-5.34M
Driftsinntekter (TTM)-70.36M
Netto inntekt (TTM)-69.53M
EPS (TTM)-0.74
EPS (1 år fremover)-

Marginer

Loading...
Marginer-data
Bruttomargin (TTM)-92.90%
Driftsmargin (TTM)-1224.43%
Fortjenestemargin (TTM)-1210.15%

Balanse

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
Kontanter3.74M
Netto fordringer6.34M
Samlede omløpsmidler14.35M
Goodwill0.00
Immaterielle eiendeler0.00
Eiendom, anlegg og utstyr0.00
Sum eiendeler29.30M
Leverandørgjeld9.54M
Kortsiktig/nåværende langsiktig gjeld13.19M
Sum kortsiktig gjeld25.85M
Sum gjeld26.56M
Aksjonærenes egenkapital2.74M
Netto varige driftsmidler1.86M

Kontantstrøm

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
Kontantstrøm fra drift (TTM)-65.28M
Kapitalutgifter (TTM)324.00K
Fri kontantstrøm (TTM)-65.61M
Utbetalt utbytte (TTM)0.00

Finansielle inntekter

Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
Egenkapitalavkastning-2535.00%
Avkastning på eiendeler-237.33%
Avkastning på investert kapital-456.69%
Kontantavkastning på investert kapital-430.90%

AKSJEINFORMASJON

Aksjediagram

Loading...
Aksjekurs-data
Åpning0.46
Daglig høy0.47
Daglig lav0.44
Daglig volum1.67M
Tidenes høyeste515.20
1 år analytikerestimat100.00
Beta1.61
EPS (TTM)-0.74
Utbytte per aksje-
Ex-div dato-
Neste dato for resultatpresentasjon31 Oct 2022

Nedsidepotensial

Loading...
Nedsidepotensial-data
AGRXS&P500
Nåværende prisfall fra toppnotering-99.91%-12.18%
Høyeste prisfall-99.91%-56.47%
Dato for høyeste fall25 Aug 20229 Mar 2009
Gj.snittlig fall fra topp-69.02%-11.38%
Gj.snittlig tid til ny topp90 days12 days
Maks tid til ny topp1855 days1805 days
SELSKAPSOPPLYSNINGER
AGRX (Agile Thrpe) company logo
Markedsverdi
14.18M
Markedsverdi kategori
Small-cap
Beskrivelse
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Ansatte
30
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Alfred F. Altomari
Land
USA
By
Princeton
Aksjetype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Alle nyheterPressemeldinger
PRINCETON, N.J., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that Chairman and Chief Executive Officer Al Altomari and Vice Pres...
6. september 2022
Before we start, let me remind you that today's call will include forward-looking statements based on current expectations, including statements concerning our financial outlook and financing prospect...
12. august 2022
Second Consecutive Quarter of Increase in Twirla Demand and Decrease in Company Operating Expenses Cash on Hand Expected to Fund Operations Through 2022 Company Announces Twirla® Product Supply Agreem...
11. august 2022
Live Conference Call and Webcast at 4:30 p.m. ETPRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report...
28. juli 2022
Maxim Group upgraded Agile Therapeutics Inc (NASDAQ: AGRX) to Buy from Hold with a price target of $1, saying it should be better positioned to begin to rebound. Agile recently closed an equity offeri...
26. juli 2022
In this article, we discuss the 10 best penny stocks to buy in July. If you want to see only the absolute top penny stocks to buy this month, check out 5 Best Penny Stocks to Buy in July. Penny stocks...
14. juli 2022
Agile Therapeutics Inc's (NASDAQ: AGRX) Twirla, the only low-dose transdermal hormonal contraceptive, should have tailwinds protected after the Supreme Court overturned Roe vs. Wade ruling that legali...
12. juli 2022
Agile Therapeutics Inc (NASDAQ: AGRX) expects Q2 FY22 Twirla demand to be at the mid-point of the earlier provided outlook of 20,000 - 22,000 cycles (new range 21,000 - 21,500 cycles). It represents a...
12. juli 2022
Twirla® Demand Guidance (Total Cycles) Expected to be at Midpoint of Guided Range Operating Expenses (OPEX) Expected to be Below Guided Range PRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) -- Agile T...
12. juli 2022
PRINCETON, N.J., July 08, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and CEO Al Altomari will be participating in a v...
8. juli 2022
Neste side